KATHRYN ROBERTSON: Open Payments
NPI 1386900983 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 106 payments from 17 companies in 2025. Trend: 2023 $1,645 · 2024 $1,691 · 2025 $2,262
Food & beverage: $2,262
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $681 |
| Janssen Biotech, Inc. | 22 | $328 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $239 |
| GENZYME CORPORATION | 6 | $160 |
| Ipsen Biopharmaceuticals, Inc | 6 | $136 |
| Celltrion USA Inc. | 6 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $119 |
| PFIZER INC. | 3 | $76 |
| Phathom Pharmaceuticals, Inc. | 4 | $67 |
| Ardelyx, Inc. | 4 | $64 |
Products named: SKYRIZI, TREMFYA, XIFAXAN, RINVOQ, DUPIXENT, LINZESS, IQIRVO, VEGZELMA.
Industry payments across VA — which companies pay providers there.
